(Q43858079)

27 November 2017

Essential criteria for evaluation of pneumococcal conjugate vaccine candidates (English)

1 reference

pneumococcal conjugate vaccine

27 November 2017

1 reference

Peter Paradiso

1

1 reference

PubMed ID

19683657

27 November 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

27 November 2017

1 reference

27 November 2017

27 Suppl 3

1 reference

27 November 2017

C15-8

1 reference

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.06.008

10.1016/J.VACCINE.2009.06.008

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference

PubMed ID

19683657